Lurasidone Hydrochloride Tablet, Film Coated
Product Images NDC 46708-494

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Lurasidone Hydrochloride (NDC 46708-494). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lurasidone-120 (Lurasidone 120mg)

Label for Lurasidone Hydrochloride tablets 120 mg manufactured by Alembic Pharmaceuticals Limited. The label indicates the film-coated tablet contains 120 mg of lurasidone hydrochloride, packaged as 30 tablets. Storage instructions specify keeping at 25°C with permitted excursions. The label includes the NDC number 46708-498-30 and a barcode.*

FDA Label Image

Lurasidone-20mg.jpg (Lurasidone 20mg)

Label for Lurasidone Hydrochloride tablets 20 mg, film-coated oral tablets. The label includes dosage strength (20 mg), quantity of 30 tablets, and mentions Alembic Pharmaceuticals Limited as the manufacturer. It also contains storage instructions and a pharmacist dispensing warning to provide the accompanying Medication Guide.*

FDA Label Image

Lurasidone-40mg.jpg (Lurasidone 40mg)

Label for Lurasidone Hydrochloride 40 mg film-coated tablets by Alembic Pharmaceuticals Limited. The label includes dosage strength, NDC 46708-495-30, quantity of 30 tablets, storage instructions, and a pharmacist warning to dispense the medication guide. The label design features the Alembic logo and barcode.*

FDA Label Image

Lurasidone-60mg.jpg (Lurasidone 60mg)

Lurasidone Hydrochloride 60 mg film-coated tablets packaging label from Alembic Pharmaceuticals Limited. The label displays the NDC 46708-496-30, dosage strength, quantity of 30 tablets, and storage instructions. It includes a pharmacist warning to dispense the medication guide to each patient.*

FDA Label Image

Lurasidone-80mg.jpg (Lurasidone 80mg)

Lurasidone Hydrochloride 80 mg film-coated tablets packaging label. The label includes the active ingredient strength, manufacturer Alembic Pharmaceuticals Limited, dosage form as tablets for oral use, and a 30-tablet count. It features storage instructions, pharmacist dispensing guidance, and an NDC number 46708-497-30.*

FDA Label Image

Lurasidone-figure-1.jpg (Lurasidone Figure 1)

A pharmacokinetic chart showing the impact of various interacting drugs on Lurasidone Hydrochloride levels. The graph presents fold changes and 90% confidence intervals in Cmax and AUC values relative to Lurasidone alone, for strong and moderate CYP3A4 inhibitors and inducers such as Ketoconazole, Diltiazem, Rifampin, and Lithium.*

FDA Label Image

Lurasidone-figure-2.jpg (Lurasidone Figure 2)

A pharmacokinetic interaction graph showing fold change and 90% confidence intervals of various interacting drugs relative to the interactive drug alone. The graph includes drugs such as Digoxin, Midazolam, Ethinyl Estradiol, Norelgestromin, and Lithium, with measures of Cmax, AUC, and Ctrough plotted on a horizontal axis indicating change values from -1 to 1.*

FDA Label Image

Lurasidone-figure-3.jpg (Lurasidone Figure 3)

A forest plot chart depicting the pharmacokinetic (PK) fold change and 90% confidence intervals (CI) for Lurasidone Hydrochloride in various conditions. It compares Cmax and AUC values in mild, moderate, and severe renal and hepatic impairment, and by population descriptors such as gender (females) and race (Asian) relative to reference groups.*

FDA Label Image

Lurasidone-str.jpg (Lurasidone Str)

Chemical structure diagram of Lurasidone Hydrochloride, showing the molecular arrangement including rings and functional groups typical of this active pharmaceutical ingredient.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.